Two ultraviolet (UV)-spectrodensitometric methods were proposed for the separation and determination of binary and ternary mixtures containing proton pump inhibitors (PPIs). Method A was developed for the assay of omeprazole, panoprazole, rabeprazole, and lansoprazole in binary mixtures with domperidone (DOM) using their isoabsorptive points. Method B was developed for the determination of a ternary mixture containing omeprazole, tinidazole, and clarithromycin. It depends on using malonic acid-acetic anhydride as a spraying reagent to form yellow color (for omeprazole) and dark brown color (for clarithromycin) that are measured at λ max = 350 nm and λ max = 492 nm, respectively, while tinidazole was measured by UV at λ max = 310 nm. For method A, Beer's law was obeyed for all studied PPIs and domperidone in the concentration range of 180-1440 and 120-720 ng spot −1 , respectively. The detection limits for proton pump inhibitors and domperidone were 48.05-73.45 and 30.74-32.50 ng spot −1 , respectively, and the quantitation limits were 145.59-222.47 and 93.14-98.48 ng spot −1 , respectively. For method B, Beer's law was obeyed for omeprazole, clarithromycin, and tinidazole in the concentration range of 180-480, 2250-6000, and 30-180 ng spot −1 , respectively. The detection limits for omeprazole, clarithromycin, and tinidazole were 20.36, 272.60, and 2.05 ng spot −1 , respectively, and the quantitation limits were 61.7, 825.9, and 6.2 ng spot −1 , respectively, for the investigated drugs.
Introduction
High-performance thin-layer chromatography (HPTLC) is one of the most widely used techniques for the separation and iden-tification of drugs [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . It is an ideal technique because of its simplicity, low cost, selectivity, sensitivity, and ability to be performed without a remote area (away from a laboratory) with limited volumes of solvents [12] . Proton pump inhibitors (PPIs), namely, omeprazole (OMZ), pantoprazole (PAN), rabeprazole (RAB), and lansoprazole (LAN), are occasionally prescribed with the prokinetic drug, domperidone (DOM), in binary mixtures to treat peptic ulcers or stomach ulcers, to prevent accumulation of food in gastrointestinal tract (GIT) and to prevent emesis. Sometimes, they are administered separately and commonly administered in binary mixture form in capsules [13] . Although dosage forms containing such mixtures are not available until now in the Egyptian drug market, many of such mixtures are commercially available in Indian and European drug markets, e.g., Pan-D ® , Rab-D ® , and Topdom ® tablets. OMZ is occasionally prescribed with the antifungal tinidazole (TNZ) and the antibiotic clarithromycin (CLM) in a ternary mixture to treat peptic ulcers or stomach ulcers caused by H. pylori. Sometimes, they are administered separately and commonly in a ternary mixture as capsules (Helicure ® capsule) [14] . This mixture needs quantitative methods for the simultaneous determination of all components. The only reported method for the determination of this ternary mixture is an ultraviolet (UV) method that utilizes derivative spectrophotometry and absorption ratio [15] , with low sensitivity. The present work was aimed at studying TLC separation of these PPIs binary and ternary mixtures followed by spectrodensitometry. Method A depends on the separation of synthetic binary mixture containing the investigated PPIs: OMZ, PAN, RAB, and LAN, with DOM using only one modified mobile phase that saves time, solvents, and effort, followed by spectrodensitometry and determination of these studied mixtures at their isoabsorptive points in the range of 250-350 nm. Method B was aimed at studying TLC separation of the ternary mixture of OMZ, CLM, and TNZ followed by spectrodensitometry using malonic acid in acetic anhydride for visualization and quantitative determination of OMZ and CLM. However, TNZ does not give any color with this reagent, and thus, it can be determined by UV-spectrodensitometry on the same TLC plate. Figure 1 shows the chemical structures of the studied mixtures. -A test tube atomizer (12 mL) (Desaga GmbH, Wiesloch, Germany) was connected to a positive-pressure outlet valve of a membrane pump (Cole-Parmer, Chicago, USA).
Materials and Reagents

Reagents
-Methanol, ethyl acetate, acetonitrile (Fisher Scientific Limited, United Kingdom), benzene (E. Merck, Darmstadt, Germany), acetic anhydride (El-Nasr Chemical Co., Cairo, Egypt) -Chloroform (HiPerSolv, England), n-hexane (Fisons Scientific Equipment, United Kingdom), and malonic acid (Sigma-Aldrich Co., England) were of analytical-reagent grade. Water used is double distilled water.
-Malonic acid reagent: 2 g dissolved in 10 mL acetic anhydride.
Pharmaceuticals
OMZ, RAB, and CLM were supplied as a gift from Sigma, Quesna, El-Menoufia, Egypt. PAN was supplied as a gift from Unipharma, Cairo, Egypt. LAN was kindly supplied by quality control centre, Giza, Egypt. TNZ was obtained as a gift from Pfizer, Cairo, Egypt, and DOM was obtained as a gift from Sedico, 6th of October, Egypt. All drugs were checked for purity by pharmacopoeial methods [16, 17] 
Preparation of Standard Synthetic Mixture
For Method A
Omeprazole-domperidone, lansoprazole-domperidone, rabeprazole-domperidone, and pantoprazole-domperidone
An accurately weighed amount of each of proton pump inhibitor (OMZ, LAN, RAB, and PAN: 20, 20, 20, and 15 mg, respectively) and 10 mg DOM were transferred into a 25-mL calibrated flask containing 10 mL methanol, shaken for 5 min and sonicated for another 5 min. Then, aliquot volumes 1, 2, 3, 4, 5, and 6 mL of each of the prepared mixture solutions were transferred into a 10-mL calibrated flask and completed to the mark with methanol.
For Method B
An accurately weighed amount equivalent to 20 mg, 250 mg, and 500 mg of standard OMZ, CLM, and TNZ, respectively, was transferred into a 50-mL calibrated flask containing 20 mL methanol, sonicated for 5 min and completed to the volume with methanol so as to obtain a stock solution containing 0.4, 5.0, and 10 mg mL −1 of OMZ, CLM, and TNZ, respectively.
For Omeprazole and Clarithromycin Series of Standard Solutions
Aliquot volumes 1.5, 2, 2.5, 3, 3.5, and 4 mL of the prepared stock solution were transferred to a 10-mL calibrated flask and diluted to the mark with methanol to obtain the following concentrations: 0.06-0.16 mg mL -1 and 0.75-2.0 mg mL −1 for OMZ and CLM, respectively. Then, the general procedure was followed on the same plate to obtain the calibration curves for the determination of OMZ and CLM.
For Tinidazole Standard Solution
Successive dilutions were made by transferring 1 mL of the prepared stock solution containing 10 mg of TNZ into a 100-mL calibrated flask and making up the volume with methanol to obtain stock solution containing 100 µg mL −1 . Then, aliquot volumes 1, 2, 3, 4, 5, and 6 mL of this stock solution were transferred to a 10-mL standard flask and made up the volume with methanol to obtain concentrations in the range of 10-60 µg mL −1 . The general procedure was followed on the TLC plate to obtain the calibration curve for the determination of TNZ.
Preparation of Sample Solutions: Helicure ® Capsules (Method B)
For Omeprazole and Clarithromycin
Ten capsules were weighed and evacuated, and the contents were finely powdered and mixed thoroughly. An accurately weighed amount of the powder -obtained from capsule contents equivalent to 20 mg OMZ, 250 mg CLM, and 500 mg TNZwas transferred into a 50-mL calibrated flask, dissolved in about 25 mL methanol, sonicated for 5 min, and diluted to the volume with methanol; the solution was then centrifuged for about 20 min and filtered, and the first portion of the filtrate was rejected. The obtained filtrate contained 0.4 mg mL −1 , 5 mg mL −1 , and 10 mg mL −1 of OMZ, CLM, and TNZ, respectively. Then, the procedure was completed as under preparation of synthetic mixture for OMZ and CLM starting from "Aliquot volumes 2, 3, and 3.5 mL of the stock solution were transferred to a 10-mL calibrated flask and completed to the volume with methanol to…"
For Tinidazole
From the obtained filtrate, 1 mL containing 10 mg of TNZ was transferred into a 100-mL calibrated flask and made up the volume with methanol to obtain stock solution containing 100 µg mL −1 . Then, the procedure was completed as under preparation of synthetic mixture for TNZ starting from "Aliquot volumes 2, 4, and 6 mL of the stock solution were transferred to a 10-mL calibrated flask and completed to the volume with methanol to…"
Chromatographic Conditions
Sixty four milliliters of the mobile phase were poured into TLC tank that was lined with a thick filter paper to help saturation of the tank. The tank was then tightly covered with a lid and presaturated with the mobile phase system vapors for at least 30 min at room temperature (25 ± 1°C) before use. The size of the plate used directly for analysis was 10 cm × 10 cm. The samples were spotted in the form of bands of width 6 mm with CAMAG microliter syringe on silica gel F 254 nm (10 cm × 10 cm with 0.2mm thickness; E. Merck, Germany) using CAMAG Linomat 5. A constant application rate of 150 nL s −1 was employed, and space between two bands was 1.0 cm. The sample-loaded TLC plate was transferred to the TLC tank, and the plate was then Absorption spectra of OMZ, RAB (1), and DOM (2).
Figure 3
Absorption spectra of LAN (1) and DOM (2).
Figure 4
Absorption spectra of PAN (1) and DOM (2).
Figure 5
TLC-densitograms of the separated binary mixtures containing the studied proton pump inhibitor.
developed until the solvent front moved about three-fourths of the length of the plate (about 10 min). The TLC plate was taken off and air-dried for 5 min. The slit dimension was kept at 6 mm × 0.45 mm, using CAMAG TLC scanner in reflectance-absorbance mode. The source of radiation used deuterium lamp emitting radiation in the range 190 nm to 350 nm for method A and 190 nm to 500 nm for method B.
General Procedures
For Method A
Three microliters of the working standard solutions were spotted on the start line of the TLC plate using the specified TLC Hamilton glass syringe. The plate was then allowed to be air-dried for 5 min before its transfer to TLC tank for the development. The plate was developed with the selected mobile phase: mixture of ethyl acetate-methanol-benzene-acetonitrile (25:20:40:15, v/v) until the ascended solvent front moved about three-fourths of the length of the plate. The plate was then airdried for about 5 min and viewed under UV lamp. The TLC plate was then scanned using TLC scanner for the studied mixtures at wavelengths from 250-350 nm, taking isoabsorptive points for measurement of such mixtures. The following wavelengths were used:
OMZ-DOM and RAB-DOM 293 nm, LAN-DOM 286 nm, PAN-DOM 287 nm.
For Method B
Three microliters of the working standard or sample solutions were spotted on the start line of the TLC plate using the speci- fied TLC Hamilton glass syringe. The plate was then allowed to be air-dried for 5 min before its transfer to TLC tank for the development. The plate was developed with the selected mobile phase: a mixture of chloroform-n-hexane-methanol (30:40:10, v/v) until the ascended solvent front moved about three-fourths of the length of the plate. The plate was then air-dried for about 5 min and viewed under UV lamp. The TLC plate was then scanned using TLC scanner for TNZ at 310 nm. The plate was sprayed with 10 mL of the spraying reagent malonic acid keeping the distance between the sprayer and the plate at about 30 cm and then placed in hot air oven at 100°C for 20 min. The yellow and dark brown spots developed for OMZ and CLM were measured at 350 nm and 492 nm, respectively.
Results and Discussion
Optimization of Chromatographic Conditions for Method A
Mobile Phase
Different solvent systems were tried for the separation of each of the studied mixtures. Compact spots and complete separation of all studied drugs were obtained using mixture of ethyl acetate-methanol-benzene-acetonitrile (25:20:40:15, v/v). This solvent system was used throughout the study for method A.
Spectral Analysis
Absorption spectra of the studied mixtures were recorded at wavelengths in the range 250-350 nm to determine isoabsorptive points for each binary mixture. The isoabsorptive points determined were taken for the spectrodensitometric simultaneous determination of these mixtures where 293 nm was used for both OMZ-DOM and RAB-DOM mixtures, 286 nm was used for LAN-DOM mixture, and 287 nm for PAN-DOM mixture. Figures 2-4 show absorption spectra of the studied drugs in binary mixtures after scanning with CAMAG TLC scanner, respectively, while Figure 5 shows densitograms of the separated binary mixtures.
Optimization of Chromatographic Conditions for Method B
Mobile Phase
Different solvent systems were tried for the separation of the three investigated drugs. Compact spots as well as complete separation of all studied drugs were obtained using mixture of chloroform-n-hexane-methanol (30:24:10, v/v).
Spraying Reagents
Several spraying reagents have been tried for the detection of OMZ, TNZ, and CLM such as Dragendorff's reagent, Marquis reagent, iodine vapors, ninhydrin, and malonic acid in acetic anhydride as well as many reagents that may give colored spots with all the studied drugs. It was found that no spraying reagent was suitable for the determination of all these cited drugs, but there are reagents that gave only colored spots with OMZ and CLM such as Dragendorff's reagent, Marquis reagent, iodine Average of six replicates c) Among all the studied spraying reagents, malonic acid in acetic anhydride was the most suitable one for OMZ and CLM. Thus, besides its low cost, it needs low concentrations of the drugs to produce colored spots, and its background interference was minimal. However, spraying with malonic acid in acetic anhydride did not give colored spot with TNZ since it is not a tertiary amine. Accordingly, TNZ was measured by UV-spectrodensitometry at 310 nm.
Coefficient of variation
Spectral Analysis
Absorption spectrum of TNZ was scanned in the UV range from 250 to 400 nm, while absorption spectra of both OMZ and CLM, after spraying with malonic acid reagent, were scanned in a range of 300-500 nm. It was found that maximum absorptions for TNZ and the chromogens obtained from OMZ and CLM were at wavelengths of 310 nm, 350 nm, and 492 nm, respec- tively. Figure 6 shows absorption spectra of the three studied drugs in ternary mixture after scanning with CAMAG TLC scanner, while Figure 7 shows densitograms of the separated ternary mixtures.
Analytical Method Validation
The proposed methods A and B were validated according to the International Conference on Harmonization (ICH) guidelines [18] and also complied with the United States Pharmacopeia (USP) 31 [17] . All results were expressed as percentages, where n represents the number of values. For the statistical analysis, Excel 2003 (Microsoft Office) was used. A 5% significance level was selected. The developed TLC method was validated for the following parameters.
Linearity
The linear regression data for the calibration curves in method A proved a good linear relationship over the concentration ranges: 240-1440, 240-1440, 180-1080, 240-1440, and 120-720 ng spot −1 for OMZ, LAN, PAN, RAB, and DOM (in binary mixtures), respectively. For method B, linear regression 
Accuracy
The accuracy of the method was determined by investigating the recovery percentage of each of the studied mixtures at three concentration levels. These ranges cover the low, medium, and higher ranges of the calibration curve (six replicates of each concentration of each mixture component). The resulting spots were analyzed by using the above described spectrodensitometric method, and concentration of each component was calculated from the calibration curves carried out on the corresponding TLC plate. Accuracy was expressed as a recovery percentage (observed concentration × 100/theoretical concentration). Results given in Table 2 for method A and B, respectively, show good accuracy and recovery percentages.
Precision
Repeatability of the sample application and measurement of the optical density, expressed as peak area, were carried out using six replicates of the same spot at three concentration levels. These ranges cover the low, medium, and higher ranges of the calibration curve (six replicates of each concentration). The inter-day and intra-day precisions were evaluated by the corresponding peak areas. The obtained results shown in Table 3 revealed good precision (% RSD ≤ 3.73 and ≤ 4.01) for the proposed methods A and B, respectively.
Sensitivity
The sensitivity of the method was confirmed in terms of limit of detection (LOD), and limit of quantitation (LOQ) [18] for all components of the studied mixtures: LOD or LOQ = K×SD a /b, where K is a numerical constant, K = 3.3 for LOD and K = 10 for LOQ, SD a is the standard deviation of the intercept, and b is the slope of the calibration curve. The limits of detection and quantitation for all the studied drugs indicate high sensitivity of the proposed methods as shown in Table 1 for methods A and B, respectively.
Robustness
Robustness was examined by evaluating the influence of small variation in the experimental parameters on the analytical performance of the proposed methods [19] . The studied parameters were the following: the composition of the mobile phase, amount of the mobile phase, time from spotting to development, time from development to scanning (for both methods A and B), and amount of spraying reagents, heating time, and temperature (for method B only). It was found that slight variation of these variables did not significantly affect the performance of both proposed methods A and B as shown in Tables 4 and 5 , respectively. This indicates that the proposed methods are robust.
Analysis of Laboratory Prepared Mixtures
For Method A
Binary mixtures containing different ratios of the drugs as shown in Table 6 were prepared. Then, the proposed spectrodensitometric method A was applied for the simultaneous determination of the components in the prepared synthetic mixtures. Recovery percentages were obtained with coefficient of variation not more than 2.36%. Thus, the proposed spectrodensitometric method A can be used routinely for the quality control of pharmaceutical binary mixtures containing PPIs (OMZ, LAN, PAN, or RAB) with DOM.
For Method B
Mixtures containing different ratios of the three drugs as shown in Table 7 were prepared. Then, the proposed spectrodensitometric method was applied for analysis of the three drugs in the prepared synthetic mixtures. Recoveries ranged from 99.9 to 102.9, 98.9 to 101.4, and 98.1 to 103.1% for OMZ, CLM, and TNZ, respectively, with coefficient of variation not exceeding 3.22%. Thus, the proposed spectrodensitometric method can be used routinely for the quality control of pharmaceutical ternary mixtures of OMZ, CLM, and TNZ.
Application of the Proposed Method B for the Analysis of Helicure ® Capsules
The proposed method B was applied successfully for determination of the studied drugs in their pharmaceutical dosage form (Helicure ® capsules) that contains a mixture of these drugs. Three replicate measurements were made in each case, and the results obtained were compared with a previously reported method [20] . No significant difference was found by applying tand F-tests at 95% confidence level indicating good accuracy and precision (Table 8 ). Figures 8-10 show the developed TLC plates for TNZ (UV measurement) and for OMZ and CLM (after spraying with malonic acid reagent). Recovery studies were also carried out using standard addition method [21] . The results in Table 8 indicate good recoveries and confirm that there is no interference from frequently encountered excipients or additives, if any.
The Reaction Mechanism for OMZ and CLM Interaction with Malonic Acid Acetic Anhydride Reagent
Groth and Wallerberg [22] have postulated a structure of the mixed anhydride of malonic acid and acetic anhydride ( Figure  11 ). In the present work, it seems apparent that the final product results from base catalyzed condensation reaction of the mixed anhydride of malonic acid and acetic anhydride, where the tertiary amine groups of OMZ and CLM act as the basic catalyst ( Figure 11 ).
Conclusion
TLC-spectrodensitometric method A was developed for separation and quantitative determination of binary mixtures containing OMZ, LAN, PAN, or RAB with DOM. TLC-spectrodensitometric method B was developed for separation and quantitative determination of OMZ, CLM, and TNZ in synthetic mixtures and dosage form (Helicure ® capsules). TLC-spectrodensitometric method B was developed for separation and quantitative determination of binary mixtures containing OMZ, LAN, PAN, or RAB with DOM. Both the proposed methods are highly sensitive comparing to the reported UV derivative spectrophotometric method [15] (for method B) or reported TLC and HPTLC methods [2] [3] [4] [5] [6] [7] [8] (for method A) with lower detection limit. In addition, it is simpler, less expensive, and less time-consuming than the similar reported HPLC method [20] . Therefore, the proposed methods could be applied successfully for the assay of the investigated binary and ternary mixtures in pharmaceutical dosage forms as well as in quality control laboratories.
